Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CENTURY ALUMINUM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Century Aluminum Co. - CENX
-
Blue Gold Limited Signs Purchase Agreement for Gold & Copper Mining Lease, Marking First Step in Broader Planned M&A Growth Strategy
-
Nasdaq Halts Apollomics Inc., Ltd.
-
Brink’s Declares Quarterly Dividend
-
Woodward Announces Declaration of Dividend
-
Students: Seize the Opportunity for Full Ride to College Through Daniels Scholarship
-
The ROOT Brands Announces Upcoming Launch of KO3: Revolutionary Antarctic Krill Oil Supplement to Set New Premium Standards with Industry-First Heavy Metal-Free Certification
-
APPLOVIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AppLovin Corporation - APP
-
Lithium Chile Announces Life Offering of Up to $5,000,000
-
Xcite Resources Announces Concurrent Brokered Life Offering & Flow-Through Shares Private Placement Alongside Amending Agreements Respecting Athabasca Uranium Portfolio
-
Upwork Announces 2025 Investor Day
-
IMMUNOVANT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc. - IMVT
-
ATIF Holdings Limited enters into non-binding Letter of Intent to acquire Mask Global Market Co. Ltd.
-
LUXURBAN HOTELS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of LuxUrban Hotels Inc. – LUXH
-
APPLE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Apple Inc. - AAPL
-
UNITED NATURAL FOODS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of United Natural Foods, Inc. – UNFI
-
Lynch Carpenter Investigates Claims in Trusteed Plans Service Corporation Data Breach
-
Fanspicy Announces Expanded Payment Solutions for Creators
-
HII Hosts Marine Corps Commandant Gen. Eric Smith at Ingalls Shipbuilding
-
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
-
Silicon Valley Certification Hub Records 30% QoQ Revenue Growth as Demand for AI Certification Accelerates
-
AGILON HEALTH INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. – AGL
-
CEMATRIX to Host Investor Webcast on September 25, 2025
-
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
-
DANAHER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
-
Thor Urbana’s Siari Poised to Set New Standard for Eco-Luxury Living in Mexico
-
Mawson Infrastructure Group Inc. Shares Corporate Update
-
Purple Heart Homes and The Home Depot Foundation Celebrate 1,000th Project Together with Renovations for Army Veteran in Villa Rica
-
Carriage Services Announces the Acquisition of Faith Chapel Funeral Homes & Crematory in Pensacola, Florida
-
MICROVAST INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Microvast Holdings, Inc. - MVST
-
FIVE BELOW INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Five Below, Inc. - FIVE
-
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
-
CVB Financial Corp. Announces 144th Consecutive Quarterly Cash Dividend
-
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
-
Ryman Hospitality Properties, Inc. Declares Third Quarter Dividend
-
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
-
Toll Brothers Announces Cash Dividend
-
Opendoor Announces Inducement Grants for Newly Appointed Chief Executive Officer Under Nasdaq Listing Rule 5635(c)(4)
-
MDWerks’ Two Trees Beverage Subsidiary Announces New Collaboration with French Broad Chocolate
-
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
-
InterDigital Declares Increase in Quarterly Cash Dividend
-
Kayne Anderson Energy Infrastructure Fund Prices Private Placement of $100 Million of Notes
-
Red Cat Holdings Announces Proposed Public Offering of Common Stock
-
CooperCompanies Announces Expanded Share Repurchase Program
-
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resist
-
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
-
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
-
Fidelity D & D Bancorp, Inc. Announces Retirement of Director Richard Hotchkiss
-
FRO – Filing of Half Yearly Report
-
Vaxart Appoints W. Mark Watson as Lead Independent Director

